
%\nomenclature{}{}
%\nomenclature{}{}
%\nomenclature{}{}

\nomenclature{4E-BP}{4E-binding protein}
\nomenclature{AIC}{Akaike information criterion}
\nomenclature{AMP}{Adenosine monophosphate}
\nomenclature{AMPK}{Adenosine monophosphate-activated protein kinase}
\nomenclature{ATP}{Adenosine 5â€²-triphosphate}
\nomenclature{BDNF}{Brain-derived neurotrophic factor}
\nomenclature{BIC}{Bayesian information criterion}
\nomenclature{CaMKIII}{Calcium-calmodulin type III kinase}
\nomenclature{CR}{Caloric restriction}
\nomenclature{CS}{Cowden syndrome}
\nomenclature{CV}{Coefficient of variance}
\nomenclature{DAP1}{Death-associated protein 1}
\nomenclature{EGF}{Epidermal growth factor}
\nomenclature{eEF2K}{Eukaryotic elongation factor-2 kinase}
\nomenclature{eIF4A-G}{Eukaryotic initiation factor 4A-G}
\nomenclature{EP}{Evolutionary programming algorithm}
\nomenclature{EPO}{Erythropoietin}
\nomenclature{FKBP}{FK506-binding protein}
\nomenclature{FoxO}{Forkhead box family, subclass O}
\nomenclature{GA}{Genetic algorithm}
\nomenclature{GAB1}{Grb2-associated binder 1}
\nomenclature{GAP}{GAPase-activating protein}
\nomenclature{GAPDH}{Glyceraldehyde-3-phosphate dehydrogenase}
\nomenclature{GDP}{Guanosine diphosphate}
\nomenclature{GEF}{Guanine nucleotide-exchange factors}
\nomenclature{GRB}{Growth factor receptor-bound protein}
\nomenclature{GS}{Glycogen syhthase}
\nomenclature{GSK-3}{Glycogen syhthase kinase 3}
\nomenclature{GTP}{Guanosine-5'-triphosphate}
\nomenclature{HIF}{Hypoxia-inducible factor}
\nomenclature{HM}{Hydrophobic motif}
\nomenclature{IGF}{Insulin growth factor}
\nomenclature{IIS}{Insulin and insulin-like signalling}
\nomenclature{IR}{Insulin receptor}
\nomenclature{IRS}{Insulin receptor substrate}
\nomenclature{JNK}{c-Jun N-terminal kinase}
\nomenclature{LKB1}{Liver kinase B1}
\nomenclature{LM}{Levenberg-Marquardt algorithm}
\nomenclature{LV}{Las Vegas methods}
\nomenclature{mtDNA}{Mitochondrial DNA}
\nomenclature{$\Psi$m}{Mitochondrial (mt) membrane potential.}
\nomenclature{mSIN1}{Mammalian stress-activated protein kinase interacting protein 1}
\nomenclature{mTOR}{Mammalian target of Rapamycin}
\nomenclature{mTORC1}{Mammalian target of Rapamycin complex 1}
\nomenclature{mTORC2}{Mammalian target of Rapamycin complex 2}
\nomenclature{MC}{Monte Carlo methods}
\nomenclature{MDM2}{Murine double minute 2}
\nomenclature{MOTA}{Mean optimal transformations analysis}
\nomenclature{NF-$\kappa$B}{Nuclear factor kappa-light-chain-enhancer of activated B cells}
\nomenclature{NFL}{p70-S6K-induced negative feedback loop}
\nomenclature{ODE}{Ordinary differential equation}
\nomenclature{p.i.}{Post-induction}
\nomenclature{p70-S6K}{p70 ribosomal S6 kinase}
\nomenclature{PDK1}{Phosphoinositide-dependent protein kinase 1}
\nomenclature{PGC-1$\alpha/\beta$}{Peroxisome proliferator-activated receptor-$\gamma$ coactivator}
\nomenclature{PH}{Pleckstrin homology}
\nomenclature{PI(3,4)P2}{phosphatidylinositol (3,4)-bisphosphate}
\nomenclature{PI(4,5)P2}{phosphatidylinositol (4,5)-bisphosphate}
\nomenclature{PI(3,4,5)P3}{phosphatidylinositol (3,4,5)-trisphosphate}
\nomenclature{PI3K}{Phosphoinositide 3-kinases}
\nomenclature{PIKK}{Phosphatidylinositol kinases}
\nomenclature{PJS}{Peutz-Jeghers syndrome}
\nomenclature{PKB}{Protein kinase B, also Akt}
\nomenclature{PKC}{Protein kinase C}
\nomenclature{PRAS40}{Proline-rich Akt substrate of 40 kDa}
\nomenclature{PTEN}{Phosphatase and tensin homologue}
\nomenclature{Raptor}{Regulatory-associated protein of mTOR}
\nomenclature{Rheb}{Ras-homolog enriched in brain}
\nomenclature{Rictor}{Rapamycin-insensitive companion of mTOR}
\nomenclature{ROS}{Reactive oxygen species}
\nomenclature{RSK}{p90 ribosomal S6 kinase}
\nomenclature{SA}{Simulated annealing algorithm}
\nomenclature{SBGN}{Systems biology graphical notation}
\nomenclature{SBML}{Systems biology markup language}
\nomenclature{SD}{Steepest descent algorithm} 
\nomenclature{SGK}{Serum- and glucocorticoid-inducible kinase}
\nomenclature{SIRT1}{NAD-dependent deacetylase sirtuin-1}
\nomenclature{SH3BP4}{SH3 domain-binding protein 4}
\nomenclature{SREBP}{Sterol regulatory element binding protein}
\nomenclature{TGF-$\beta$}{Transforming Growth Factor $\beta$}
\nomenclature{TN}{Truncated-Newton algorithm}
\nomenclature{TNF-$\alpha$}{Tumour necrosis factor $\alpha$}
\nomenclature{TR}{Trust region algorithm}
\nomenclature{TSC1/TSC2}{Tuberous sclerosis complex}
\nomenclature{TSCS}{Tuberous sclerosis complex syndrome}
\nomenclature{ULK1}{Serine/threonine-protein kinase ULK1}
\nomenclature{VEGF}{Vascular endothelial growth factor}
\nomenclature{VHL}{Von Hippel-Lindau}



% ------------------------------------------------------------------------

%%% Local Variables: 
%%% mode: latex
%%% TeX-master: "../thesis"
%%% End: 
